<DOC>
	<DOCNO>NCT00633984</DOCNO>
	<brief_summary>The purpose study test drug call d-cycloserine see help people condition call social phobia . Social phobia also call `` social anxiety disorder . '' Social phobia constant fear social performance situation . Social situation include group gathering kind . Performance situation might include time person would something public , speak class meeting . A person condition worry embarrass , people 's opinion . People social phobia usually feel extremely anxious ( nervous worry ) focus attention . They often avoid social performance situation . This behavior negative effect quality live relationship . In study , want find d-cycloserine help control social phobia drug add standard treatment condition . The standard treatment cognitive-behavior therapy ( CBT ) . CBT form talk therapy involve discussion therapist , along practice feeling event person find frighten .</brief_summary>
	<brief_title>D-Cycloserine Enhancement Exposure Social Phobia</brief_title>
	<detailed_description>Inclusion criterion : 1 . Age 18 old 2 . Primary diagnosis SAD 3 . Physical examination , electrocardiogram , laboratory finding without clinically significant abnormality . 4 . Willingness ability comply requirement study protocol . Diagnostic Exclusion Criteria : 1 . A lifetime history bipolar disorder , schizophrenia , psychosis , delusional disorder obsessive-compulsive disorder ; eat disorder past 6 month ; organic brain syndrome , mental retardation cognitive dysfunction could interfere capacity engage therapy ; history substance alcohol abuse dependence ( nicotine ) last 6 month otherwise unable commit refrain alcohol use acute period study participation . 2 . Patients posttraumatic stress disorder within past 6 month exclude . Entry patient mood anxiety disorder permit social anxiety disorder judge predominant disorder , order increase accrual clinically relevant sample . Patients significant suicidal ideation ( MADRS item 10 score &gt; 3 ) enact suicidal behavior within 6 month prior intake exclude study participation refer appropriate clinical intervention . 3 . Patients must concurrent psychotropic medication ( e.g. , antidepressant , anxiolytic , beta blocker ) least 2 week prior initiation randomize treatment . 4 . Significant personality dysfunction likely interfere study participation . 5 . Serious medical illness instability hospitalization may likely within next year . 6 . Patients current past history seizures 7 . Pregnant woman , lactate woman , woman childbearing potential use medically accept form contraception ( e.g. , IUD , oral contraceptive , barrier device , condom foam , implant progesterone rod stabilize least 3 month ) . 8 . Any concurrent psychotherapy initiate within 3 month baseline , ongoing psychotherapy duration direct specifically toward treatment GSAD exclude . Prohibited psychotherapy include CBT psychodynamic therapy focus explore specific , dynamic cause phobic symptomatology provide management skill . General supportive therapy initiate &gt; 3 month prior acceptable . 9 . Prior non-response adequately-delivered exposure ( i.e. , define patient 's report receive specific regular exposure assignment part previous treatment ) exclude participant study . 10 . Patients history head trauma cause loss consciousness , seizure ongoing cognitive impairment . 11 . Patients receive isoniazid . 12 . Patients unable understand study procedure participate inform consent process .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>1 . Male female outpatient &gt; 18 year age primary psychiatric diagnosis ( designate patient important source current distress ) generalize social anxiety disorder ( GSAD ) define DSMIV criterion . 2 . A total score &gt; 60 LSAS . 3 . Physical examination , electrocardiogram , laboratory finding without clinically significant abnormality . 4 . Willingness ability comply requirement study protocol . 1 . A lifetime history bipolar disorder , schizophrenia , psychosis , delusional disorder obsessivecompulsive disorder ; eat disorder past 6 month ; organic brain syndrome , mental retardation cognitive dysfunction could interfere capacity engage therapy ; history substance alcohol abuse dependence ( nicotine ) last 6 month otherwise unable commit refrain alcohol use acute period study participation . 2 . Patients posttraumatic stress disorder within past 6 month exclude . Entry patient mood anxiety disorder permit social anxiety disorder judge predominant disorder , order increase accrual clinically relevant sample . Patients significant suicidal ideation ( MADRS item 10 score &gt; 3 ) enact suicidal behavior within 6 month prior intake exclude study participation refer appropriate clinical intervention . 3 . Patients must concurrent psychotropic medication ( e.g. , antidepressant , anxiolytic , beta blocker ) least 2 week prior initiation randomize treatment . 4 . Significant personality dysfunction likely interfere study participation . 5 . Serious medical illness instability hospitalization may likely within next year . 6 . Patients current past history seizures 7 . Pregnant woman , lactate woman , woman childbearing potential use medically accept form contraception ( e.g. , IUD , oral contraceptive , barrier device , condom foam , implant progesterone rod stabilize least 3 month ) . 8 . Any concurrent psychotherapy initiate within 3 month baseline , ongoing psychotherapy duration direct specifically toward treatment GSAD exclude . Prohibited psychotherapy include CBT psychodynamic therapy focus explore specific , dynamic cause phobic symptomatology provide management skill . General supportive therapy initiate &gt; 3 month prior acceptable . 9 . Prior nonresponse adequatelydelivered exposure ( i.e. , define patient 's report receive specific regular exposure assignment part previous treatment ) exclude participant study . 10 . Patients history head trauma cause loss consciousness , seizure ongoing cognitive impairment . 11 . Patients receive isoniazid . 12 . Patients unable understand study procedure participate inform consent process .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Cognitive Behavioral Group Therapy</keyword>
	<keyword>D-cycloserine</keyword>
</DOC>